Introduction and objectives. Prosthetic valve infective endocarditis is a c
omplication of valvular replacement surgery with a high morbimortality duri
ng the in-hospital phase and an important risk of complications during foll
owup. The objective of the present study is to assess the clinical features
and the short and long-term prognosis of this disease.
Patients and methods. A prospective study of 43 consecutive cases of prosth
etic valve endocarditis in non-addict patients from January 1987 to March 1
997.
Results. The mean age was 51 +/- 16 years. Eight patients (19%) had early p
rosthetic valve endocarditis (two months following heart surgery), fourteen
patients (32%) had intermediate (between 2 and 12 months post surgery) and
twenty-one (49%) had late prosthetic valve endocarditis (more than one yea
r after heart surgery). Transesophageal echocardiography was performed in 3
2 patients with a sensibility of 81%. Complications occurred in 86% of pati
ents and 53% of patients underwent surgery during the active phase (25% was
emergency surgery). Inpatient mortality was 23% (50% in early prosthetic v
alve endocarditis). After a mean follow-up of 56 months there were 5 cases
of recurrence, four patients required late surgery and 5 patients died. Sur
vival (excluding early mortality) was 82% at 5 years with no significant di
fferences among patients who received only medical treatment and those who
underwent surgery in the active phase.
Conclusions. Early mortality of prosthetic valve endocarditis is, according
to our experience of 20%. The prognosis of survivors to the active phase i
s favourable in the majority. Early prosthetic valve endocarditis still cau
ses a high mortality rate despite the use of combined medical-surgical trea
tment in most cases.